Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control Trial (PREHAB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02780921

Recruitment Status : Unknown

Verified January 2017 by University Hospital, Clermont-Ferrand.
Recruitment status was: Recruiting

First Posted : May 24, 2016

Last Update Posted : January 25, 2017

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Direction Générale de l'Offre de Soins

Information provided by (Responsible Party):

University Hospital, Clermont-Ferrand

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	March 2018
Estimated Study Completion Date :	March 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Le Roy B, Pereira B, Bouteloup C, Costes F, Richard R, Selvy M, Petorin C, Gagniere J, Futier E, Slim K, Meunier B, Mabrut JY, Mariette C, Pezet D. Effect of prehabilitation in gastro-oesophageal adenocarcinoma: study protocol of a multicentric, randomised, control trial-the PREHAB study. BMJ Open. 2016 Dec 7;6(12):e012876. doi: 10.1136/bmjopen-2016-012876.

To Top